D3 Bio pockets $200m Series A

D3 Bio, a global biotechnology company, has raised $200 million in Series A financing.

D3 Bio, a global biotechnology company, has raised $200 million in Series A financing. The investors included Boyu Capital, Matrix Partners China, Sequoia Capital China, Temasek, and WuXi AppTec.

Source: Press Release